Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The WorldWide Antimalarial Resistance Network (WWARN) has been shortlisted for a 2017 Times Higher Education (THE) Award in the ‘International Collaboration of the Year’ category.

THE awards nomination Sept 2017 poster

Known as the ‘Oscars of higher education’, the THE Awards recognise “the talent, dedication and innovation of individuals and teams across all aspects of university life”. The ‘International Collaboration of the Year’ category acknowledges “exceptional projects carried out jointly between a UK institution and one or more international partners”.

WWARN is a collaborative research network that works to provide the information necessary to optimise antimalarial treatments, in turn, reducing the number of people falling ill and dying from malaria. WWARN works with over 260 collaborators across the world. The Network is part of the Infectious Diseases Data Observatory (IDDO) (link is external), based at the University of Oxford.

The nomination recognises the results of two research projects that have led to international policy changes to help improve the outcomes of those treated with an important antimalarial medicine, dihydroartemisinin-piperaquine (DP).

The full story is available on the WWARN website

Similar stories

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings

Combating drug-resistant malaria

MORU research has contributed to strategies to eliminate malaria in the Greater Mekong Sub-region, helping to prevent the spread of drug-resistant malaria and improving health provision and outcomes for remote communities.

Antimalarial chemoprophylaxis for forest goers could help accelerate malaria elimination in Cambodia

Giving people antimalarials during and after visiting the forest reduced their risk of contracting malaria 6-fold, and could be the missing piece towards eliminating malaria in Asia-Pacific and South America, say Mahidol and Oxford University researchers in a study published in The Lancet Infectious Diseases.

Call for researchers: Share your country’s national COVID-19 therapeutics guidelines

The joint MORU and IDDO Study to review global COVID-19 therapeutics guidelines, led by PIs Cintia V. Cruz, Mia Cokljat and Philippe Guérin, is examining current national COVID-19 treatment recommendations to investigate the level of variation and whether they are consistent with WHO guidelines for the pharmacological prevention and treatment of COVID-19.

Three new full Oxford Professors from MORU

Three MORU Network staff awarded full professorship at the Nuffield Department of Medicine, University of Oxford.

Using mathematical modelling to fight malaria

Researchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.